Haleon plc (HLN)
USD 9.71
(-2.02%)
USD 9.71
(-2.02%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.96 Billion GBP | -6.21% |
| 2022 | 4.75 Billion GBP | 10.2% |
| 2021 | 4.31 Billion GBP | 0.0% |
| 2020 | 4.31 Billion GBP | 10.42% |
| 2019 | 3.9 Billion GBP | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.17 Billion GBP | -2.81% |
| 2024 Q2 | 1.21 Billion GBP | 10.54% |
| 2023 Q4 | 1.21 Billion GBP | 6.89% |
| 2023 FY | 4.45 Billion GBP | -6.21% |
| 2023 Q3 | 1.13 Billion GBP | -5.35% |
| 2023 Q2 | 1.19 Billion GBP | -1.4% |
| 2023 Q1 | 1.21 Billion GBP | -25.35% |
| 2022 Q3 | 1.25 Billion GBP | 7.39% |
| 2022 Q1 | 1.14 Billion GBP | 52.73% |
| 2022 Q4 | 1.62 Billion GBP | 30.0% |
| 2022 FY | 4.75 Billion GBP | 10.2% |
| 2022 Q2 | 1.16 Billion GBP | 1.48% |
| 2021 Q2 | 1.03 Billion GBP | -2.73% |
| 2021 Q3 | 1.05 Billion GBP | 1.55% |
| 2021 Q4 | 751 Million GBP | -28.48% |
| 2021 Q1 | 1.06 Billion GBP | 0.0% |
| 2021 FY | 4.31 Billion GBP | 0.0% |
| 2020 FY | 4.31 Billion GBP | 10.42% |
| 2019 FY | 3.9 Billion GBP | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 616.19 Million USD | -705.757% |
| Bausch Health Companies Inc. | 5.23 Billion USD | 5.158% |
| Catalent, Inc. | 1.7 Billion USD | -191.716% |
| Emergent BioSolutions Inc. | 1.04 Billion USD | -375.575% |
| Elanco Animal Health Incorporated | 1.61 Billion USD | -208.002% |
| Perrigo Company plc | 1.52 Billion USD | -224.828% |
| Teva Pharmaceutical Industries Limited | 4.45 Billion USD | -11.548% |
| Zoetis Inc. | 2.76 Billion USD | -79.566% |